What is the validity of the Federal Adverse Event Reporting System in contemporary clinical research?

Albert Ha; Ashkan P Langroudi; Michael L Eisenberg

doi:10.1093/jsxmed/qdae072

What is the validity of the Federal Adverse Event Reporting System in contemporary clinical research?

J Sex Med. 2024 Sep 3;21(9):744-745. doi: 10.1093/jsxmed/qdae072.

Authors

Albert Ha¹, Ashkan P Langroudi¹, Michael L Eisenberg¹

Affiliation

¹ Male Reproductive Medicine and Surgery, Department of Urology, School of Medicine, Stanford University, Stanford, CA 94305, United States.

PMID: 39228247
DOI: 10.1093/jsxmed/qdae072

No abstract available

Keywords: adverse effects; drug legislation; electronic health records; pharmacovigilance; postmarketing surveillance; therapeutic drug monitoring.

MeSH terms

Adverse Drug Reaction Reporting Systems* / standards
Biomedical Research / standards
Humans
Reproducibility of Results
United States